Pro-inflammatory cytokines of a T helper-1-signature are known to promote insulin resistance (IR) in obesity, but the physiological role of this mechanism is unclear. It is also unknown whether and how viral infection induces loss of glycemic control in subjects at risk for developing diabetes mellitus type 2 (DM2). We have found in mice and humans that viral infection caused short-term systemic IR. Virally-induced interferon-g (IFN-g) directly targeted skeletal muscle to downregulate the insulin receptor but did not cause loss of glycemic control because of a compensatory increase of insulin production. Hyperinsulinemia enhanced antiviral immunity through direct stimulation of CD8 + effector T cell function. In prediabetic mice with hepatic IR caused by diet-induced obesity, infection resulted in loss of glycemic control. Thus, upon pathogen encounter, the immune system transiently reduces insulin sensitivity of skeletal muscle to induce hyperinsulinemia and promote antiviral immunity, which derails to glucose intolerance in prediabetic obese subjects.
In Brief
It is unknown how viral infections contribute to the progression of type 2 diabetes.
Sestan and colleagues demonstrate that virus-induced interferon-g increases muscle insulin resistance, which drives hyperinsulinemia to keep euglycemia and to boost anti-viral CD8 + T cell responses.
This mechanism in obese subjects with hepatic IR derails glycemic control.
INTRODUCTION
Diabetes mellitus type 2 (DM2) is a highly prevalent (Stevens et al., 2012 ) metabolic disease, characterized by high blood glucose concentrations. The pathology of DM2 involves many organs but its main underlying mechanism is decreased insulin sensitivity of the liver and skeletal muscle and an inability of pancreatic b-cells to compensate for this defect (Defronzo, 2009) . DM2 is diagnosed based on increased concentrations of glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG) or 2-hr postprandial blood glucose (2HG) (American Diabetes Association, 2018). If these concentrations are increased, but do not reach DM2 threshold values, people are diagnosed with pre-diabetes (Abdul-Ghani et al., 2006) . Prospective studies show that changes in glycemic control occur gradually over years, but typically contain an abrupt increase in metabolic parameters preceding diagnosis of DM2 (Mason et al., 2007; Tabá k et al., 2012) . Progression from pre-diabetes to DM2 therefore appears to involve an unknown ''event'' that pushes systemic insulin resistance (IR) beyond the ability of the pancreas to compensate. DM2 is associated with chronic systemic lowgrade inflammation originating in visceral adipose tissue (VAT) (Wensveen et al., 2015b) . Obese VAT accumulates pro-inflammatory immune cells and drives a type-1 immune response, normally associated with viral infection, characterized by the production of cytokines such as tumor necrosis factor (TNF) and interleukin-1b (IL-1b) (Johnson et al., 2012; Wensveen et al., 2015a; Wensveen et al., 2015b) . Obesity thus mimics a state of chronic systemic low-grade infection and leakage of pro-inflammatory cytokines into circulation is thought to contribute to systemic IR (Johnson et al., 2012; Wensveen et al., 2015b) . Acute infection might therefore represent the ''event'' that drives rapid progression to DM2 in pre-diabetes.
Only few epidemiological studies address this topic and these do suggest that infection is associated with a higher risk of DM2 (Chen et al., 2012; Leinonen and Saikku, 1999; Roberts and Cech, 2005) . However, direct experimental evidence if and how infection impacts glycemic control are lacking. It is currently unclear what the physiological role is of reduced systemic insulin sensitivity following infection. Immune activation comes at a considerable energetic cost (Ganeshan and Chawla, 2014) as cells switch from oxidative to glycolytic metabolism (O'Neill et al., 2016) . It was therefore proposed that inflammation-induced IR is a physiological response to infection that aims to increase systemic glucose availability to activated immune cells (Kotas and Medzhitov, 2015) . However, infectioninduced acute loss of glycemic control is only observed under extreme conditions such as sepsis, whereas DM2 is associated only with low amounts of systemic inflammation (Johnson et al., 2012; Marik and Raghavan, 2004) . Alternatively, inflammationinduced IR may be a strategy of the immune system to involve endocrine mediators in the response against infection. Both cytokines and hormones regulate the metabolism of cells in response to alterations in the external environment. Frequently their receptors overlap both in the intracellular signaling pathways that they use and the effects that they mediate (Ouchi et al., 2011) . For example, receptors for both IL-6 and for the adipose tissue-derived hormone leptin signal through the Jak2-Stat3 signaling pathway (Heinrich et al., 2003; M€ unzberg and Morrison, 2015) and both molecules promote proliferation of immune cells and excretion of cytokines by macrophages (Heinrich et al., 2003) . The insulin receptor shares its downstream signaling cascade with CD28, one of the most potent costimulatory molecules for CD8 + T cells (Pessin and Saltiel, 2000; Sharpe and Freeman, 2002) . Both pathways converge on phosphatidylinositol 3 kinase (PI3K), enhancing anabolic metabolism and increasing glucose transporter amounts on the cell membrane (Frauwirth et al., 2002; Pessin and Saltiel, 2000) . IR is associated with hyperinsulinemia. Whether insulin plays a role in promoting immune responses following infection is unknown.
Here, we investigated how infection impacts insulin-mediated regulation of glycemia. We found that virally-induced IFN-g caused IR in the skeletal muscle through direct engagement of the IFN-g receptor on myocytes and down-modulation of the insulin receptor on these cells. Infection-induced selective IR drove an increase of systemic insulin concentrations to prevent hyperglycemia, but also to boost the anti-viral CD8 + T cell response through direct promotion of effector cell function. When systemic insulin sensitivity is already reduced, such as in pre-diabetic obese subjects due to hepatic IR, infection overwhelmed the ability of the endocrine system to compensate for increased muscle IR and glucose intolerance (GI) ensued. We thus identify an immune-endocrine regulatory feed-back mechanism of antiviral immunity and provide additional insights in the underlying physiology of DM2.
RESULTS

Viral Infection Causes Development of Insulin
Resistance, but not Glucose Intolerance First, we investigated whether infection impacts systemic metabolic parameters in humans. Body mass index (BMI) and blood parameters were obtained from euglycemic people with normal weight (BMI of 18-25 kg/m 2 ) and overweight (BMI > 25), diagnosed with acute respiratory infection at time of presentation of symptoms and three months later. Infection transiently increased fasting plasma insulin (FPI) in both groups ( Figure 1A ). In contrast, FPG was not significantly affected by infection (Figure 1B) . Notably, the homeostasis model assessment-insulin resistance (HOMA-IR) index values, which inversely correlate with systemic insulin sensitivity, were increased during acute infection, especially for people with overweight ( Figure 1C) . Thus, acute infection appeared to transiently decrease systemic insulin sensitivity in humans, without affecting blood glucose concentrations.
We next used murine cytomegalovirus (MCMV) as an animal model for a common human infection (Krmpotic et al., 2003) . MCMV has a broad tropism, including key organs involved in the regulation of glucose homeostasis, such as liver, VAT, pancreas, and skeletal muscle ( Figure 1D ). Animals were infected with MCMV and after 7 days subjected to an insulin tolerance test (ITT). We observed that MCMV infection resulted in transient intolerance to insulin ( Figure 1E ; S1A). To confirm that this effect was the result of IR, mice were subjected to hyperinsulinemic-euglycemic clamping on day 5 after infection. Indeed, infected animals showed a strongly reduced sensitivity to insulin in comparison to non-infected controls ( Figure 1F ; S1B), as determined by a lower glucose infusion rate (GIR). To determine whether infection-induced IR resulted in loss of glycemic control, we analyzed infected animals by glucose tolerance test (GTT). Despite IR, infection did not result in GI ( Figure 1G ). As in humans, infection was associated with elevated FPI concentrations. Moreover, following glucose challenge, increased insulin production was observed in infected animals, explaining why systemic IR does not result in GI ( Figure 1H ).
Taken together, human and mouse data show that infection transiently induces IR, but does not result in overt GI due to compensatory hyperinsulinemia.
Viral Infection Enhances Progression of Diabetes Mellitus Type 2 in Obesity
Systemic IR is the underlying cause of DM2. However, people are only diagnosed as diabetics when systemic IR has reached a level at which compensatory mechanisms fail to lower blood glucose concentrations below well-defined thresholds. Thus, (D) MCMV titters (PFU) in indicated tissues of B6 mice at day 4, 7, and 10 p.i. are shown. LD, limit of detection. (E) B6 mice were mock-infected or infected with MCMV and analyzed 7 days later by ITT. (F) B6 mice were mock-infected or infected with MCMV and analyzed 5 days later by hyperinsulinemic-euglycemic clamp. Glucose infusion rate (GIR) is shown. n = 5. (G and H) B6 mice were mock-infected or infected with MCMV and analyzed 7 days later by (G) GTT and (H) serum insulin concentrations after glucose challenge upon overnight fasting were measured. In addition, area under curve is shown. (I-K) Mice were placed on NCD or HFD for 6 weeks (''pre-diabetic'' mice) before infection with MCMV or PBS. 1 week later, they were subjected to (I) ITT or (J) GTT. (K) GTT was also performed 3 weeks after infection. (L-P) Mice were infected with MCMV simultaneously with the start of HFD. 8 weeks p.i. mice were subjected to (L) GTT and (M) ITT. In addition, (N), sizes of juxtamedullary glomeruli were determined 16 weeks p.i. (n = 5; 72 glomeruli per animal). 24 weeks p.i. (O) PAS staining of kidney sections was performed. (Green arrow) expansion of mesangial matrix and (yellow arrow) increased Bowman capsule size or (P) thickness of basement membrane are shown. (Q) MCMV infected pre-diabetic mice were treated daily with ganciclovir starting 24 h p.i. or with PBS. After 7 days, mice were subjected to GTT. The experiment in (F) was performed once. For all other experiments, a representative of three experiments is shown. For (D)-(Q), five mice were used in each group. Indicated are means ± SEM and statistical significances at *p < 0.05, **p < 0.01, ***p < 0,001 by (A-C, E-H) Student's t test or (I-Q) ANOVA followed by Bonferroni post-testing. p.i., post infection. See also Figure S1 . DM2 is diagnosed by measuring GI, rather than IR. In pre-diabetes, frequently an unknown ''event'' drives rapid development of DM2 (Tabá k et al., 2012) . To see whether infection represents such an event, animals were placed on a diet with high fatcontent (HFD), resulting in diet-induced obesity (DIO). HFD generates systemic IR and GI in 3 months (Wensveen et al., 2015a ), but after 6 weeks results only in hepatic IR, characterized by increased FPG and pyruvate intolerance ( Figure S1C and S1D), but not yet systemic IR or GI ( Figures S1E and S1F) , thus resembling human pre-diabetes (Mason et al., 2007) . Infection of 6 weeks HFD-primed (''pre-diabetic'') mice with MCMV resulted in both IR and GI ( Figures 1I and 1J ), but did not affect obesity ( Figure S1G ). To test whether other viral pathogens also affect glucose homeostasis, we infected pre-diabetic mice with lymphocytic choriomeningitis (LCMV) or influenza A virus. Both infections resulted in similar loss of glucose control as observed after MCMV infection ( Figures S1H and S1I ).
An important question from the perspective of clinical relevance is whether the impact of infection on glycemic control is transient or permanent. Indeed, we observed that three weeks after MCMV infection, pre-diabetic mice still showed increased GI ( Figure 1K ) although there was no difference in viral titers between normal chow diet (NCD) or HFD fed animals ( Figure S1J ), suggesting a long-lasting effect. When MCMV infection and HFD feeding were started on the same day, increased IR and reduced glycemic control were observed for at least 8 weeks in infected animals, compared to non-infected controls ( Figures 1L and  1M ). In contrast, the impact of Influenza A or LCMV infection on glucose intolerance of HFD-primed animals appeared to be transient ( Figure S1K and S1L).
Chronic, uncontrolled DM2 is associated with development of microvascular and macrovascular complications, such as diabetic nephropathy (DN). To investigate whether infection aggravates development of DM2-associated complications, animals were infected with MCMV on the same day when we started with HFD feeding. At 16 weeks, infection of pre-diabetic mice promoted hypertrophy of juxtamedullary glomeruli, an early sign of DN (Shahbazian and Rezaii, 2013) (Figure 1N ). After 24 weeks, histological analysis revealed more severe symptoms of DN in 10%-20% of glomeruli of infected HFD-fed mice, but not in lean or uninfected animals, whereas kidneys from obese mice were mildly affected in only 5% of glomeruli ( Figure 1O ; S1M). 24 weeks after infection, viral replication was not detectable in kidneys of mice fed either with NCD or HFD, indicating that virus-induced pathology is not directly responsible for DN ( Figure S1N ). In addition, infection with MCMV of HFD fed animals resulted in increased thickness of the basement membrane, another bona fide marker of DN ( Figure 1P ).
Our findings indicate that viral infection is an independent risk factor for development of diabetes by pre-diabetic obese individuals. To investigate whether we could therapeutically prevent GI in pre-diabetic mice, animals were treated with the antiviral drug ganciclovir starting one day after infection. Ganciclovir treatment strongly reduced viral replication ( Figure S1O ) and prevented development of virus-induced glucose intolerance in HFD primed mice ( Figure 1Q ).
In summary, viral infection of ''pre-diabetic'' obese mice causes a reduction of glycemic control and aggravates development of clinical complications associated with DM2.
Viral Infection Promotes Development of Glucose
Intolerance and Insulin Resistance through Interferon-g To gain insight in the mechanism underlying virus-induced progression of DM2 we first investigated whether viral infection affects glucose sensing by the pancreas after HFD priming. We observed that infection of pre-diabetic mice with MCMV resulted in increased FPI and enhanced insulin production following glucose challenge (Figure 2A ). To further prove that MCMV infection increases insulin secretion we calculated the insulinogenic index, which positively correlates with insulin output from pancreatic b-cells . We observed that the insulinogenic index was increased in infected, HFD-fed animals compared to controls, excluding pancreatic dysfunction as a cause for GI ( Figure 2B) .
The liver has an important role in maintaining euglycemia through gluconeogenesis, glycogenolysis, and glycogenesis. Liver diseases, including viral hepatitis, are therefore frequently associated with aberrations in glucose homeostasis (Barthel and Schmoll, 2003; Cotrozzi et al., 1997; Custro et al., 2001; Holstein et al., 2002; Picardi et al., 2006; Postic et al., 2004; Tappy and Minehira, 2001) . To investigate whether liver damage alone may be responsible for enhanced progression of GI in our model, we exposed pre-diabetic mice to the hepatotoxic compounds CCL 4 (Boll et al., 2001) or paracetamol (Mossanen and Tacke, 2015) (Figures S2A and S2B ). Neither compound induced development of GI in pre-diabetic animals ( Figure S2C and S2D).
We therefore considered the possibility that the immune system drives IR through specific cytokines following infection. Viral infection activates the inflammasome (Lamkanfi and Dixit, 2014) , which generates the pro-diabetic cytokine IL-1b (Ballak et al., 2015) . However, neither chemical inhibition of the NLRP3 inflammasome activity, nor neutralization of IL-1b with antibodies resulted in amelioration of GI following MCMV infection of pre-diabetic mice (Figures S2E and S2F) . In fact, neutralization of IL-1b increased glucose intolerance following infection, which corresponds with the previously reported positive effect of this cytokine on glycemic control . Type-1 inflammatory cytokines such as interferons and TNF have a negative impact on glucose homeostasis in the context of obesity (Fensterl and Sen, 2009; Grzelkowska-Kowalczyk and Wieteska-Skrzeczy nska, 2009; Kim and Solomon, 2010; Koivisto et al., 1989; McGillicuddy et al., 2009; Nieto-Vazquez et al., 2008; Wada et al., 2011; Yki-J€ arvinen et al., 1989) . We therefore injected lean and pre-diabetic mice with poly I:C, a strong inducer of type-1 interferons (Wu et al., 2014) . Whereas this treatment did activate peritoneal macrophages, no impact on GI was observed (Figure S2G and S2H) . TNF has been shown to induce IR in ob/ob mice through TNF receptor 1 (TNFR1) (Uysal et al., 1998) . However, deficiency for TNFR1 did not result in amelioration of GI following MCMV infection of pre-diabetic animals ( Figure S2I ). In contrast, although neutralization of interferon-g (IFN-g) was associated with increased viral titers in some tissues important for glucose homeostasis ( Figure S2J Figure 2G ). In addition, infection of HFD primed mice with m157-deficient MCMV virus (Dm157), which precludes Ly49h-mediated activation of NK cells, did not induce development of GI ( Figure S2N ). Thus, MCMV infection drives development of GI and IR in pre-diabetic mice via NK cell-derived IFN-g. In summary, virally-induced IFN-g promotes IR and GI and drives the rapid progression from pre-diabetes to DM2 in infected mice.
Interferon-g Specifically Induces Insulin Resistance of Skeletal Muscle Cells
To investigate whether systemic or local increase of IFN-g concentrations is responsible for the effect, we infected pre-diabetic mice with MCMV and plasma IFN-g concentrations were followed over time. We observed that increased blood IFN-g returned to baseline at time points when it still impacted GI and IR ( Figure 3A ). This result suggests that IFN-g either has a long-lasting effect on the ability of tissues to sense insulin or that there is a local source of IFN-g that sustains impairment of insulin sensitivity. We neutralized IFN-g starting 7 days post infection (p.i.) of HFD-primed mice, when its concentrations in the blood have returned to baseline. GI was completely prevented in treated mice ( Figure 3B ), which indicates that a local source of IFN-g drove continued GI and IR in pre-diabetic mice following infection.
Previously we showed that NK-cell-derived IFN-g promotes IR in the DIO model by inducing M1 adipose tissue macrophage ITT were performed on day 7 after infection. Infected pre-diabetic mice were injected with (E) CD4-or CD8-depleting or (F) NK-cell-depleting antibodies. Control animals were treated with isotype matched irrelevant mAbs. GTT was performed on day 7 p.i. (G) B6 or Ifng À/À mice were infected with MCMV. Ifng À/À mice were transferred with NK cells or PBS 1 day before infection and 3 days later. 5 days p.i. mice were subjected to ITT. For (A)-(G) a representative of three experiments is shown. For (A-G) five mice were used in each group. Indicated are means ± SEM. and statistical significances at *p < 0.05, **p < 0.01, ***p < 0,001 by ANOVA followed by Bonferroni post-testing. p.i., post infection. See also Figure S2 . (E) Mice either underwent sham operation or surgical excision of periepididymal fat pads (VATectomy). 2 weeks after surgery, mice were infected with MCMV and placed on HFD. GTT was performed after 8 weeks.
(F and G) Pre-diabetic Ifngr1 DAdi mice and Ifngr1 flox/flox littermates were injected with MCMV or PBS. 5 and 7 days after infection mice were subjected to (F) ITT or (G) GTT, respectively. (H-J) Mice were fed for 6 weeks with indicated diets, followed by MCMV or PBS injection. (H) FPG was determined 7 days after infection. (I) PTT was performed on day 7 after infection. (J) 7 days p.i., mice were fasted overnight, followed by injection with insulin. After 30 minutes, liver samples were isolated and pan-Akt and pAkt amounts were determined by Immuno blotting.
(legend continued on next page) (ATM) polarization (Wensveen et al., 2015a) . We hypothesized that this mechanism also operates in the context of infection. Whereas infection does enhance ATM conversion and tissue inflammation, clodronate-mediated neutralization of these cells did not prevent infection-induced GI ( Figures S3A and S3B ). To confirm that IFN-g mediates its effect in infected mice independently of macrophages, we conditionally ablated the receptor for IFN-g (IFN-gR1) on these cells. Lyz2 cre Ifngr1 flox/flox (Ifngr1 DMac ) and littermate controls were placed on HFD for 6 weeks and then infected with MCMV. Five days p.i. we observed no difference in insulin sensitivity ( Figure 3C ) or GI ( Figure 3D ) between Ifngr1 DMac and littermate controls. Thus, IFN-g mediates its effect on IR and GI in infected pre-diabetic mice independently of macrophages. We therefore considered that IFN-g directly affects insulin sensitivity of one or more organs involved in glucose homeostasis. In the DIO model, VAT is the main source of chronic systemic inflammation and plays a key role in the development of IR and GI. We have shown previously that surgical removal of VAT (VATectomy) prevents development of GI and IR in non-infected obese mice (Wensveen et al., 2015a) . We performed VATectomy 2 weeks before initiation of HFD feeding and MCMV infection. GTT was performed 10 weeks after the surgery. As expected, VATectomy reduced glucose intolerance in non-infected animals. In contrast, removal of visceral fat pads was not able to prevent infection-induced GI ( Figure 3E ). Since VATectomy does not remove all adipocyte deposits in mice, we conditionally ablated IFNgR1 from adipocytes. Prediabetic Adipoq cre Ifngr1 flox/flox mice (Ifngr1 DAdi ) were not able to prevent infection-induced IR or GI in comparison to littermate controls ( Figures 3F and 3G) . Thus, adipocytes do not play a major role in infection-induced GI in pre-diabetic mice.
To investigate whether infection reduces insulin sensitivity of the liver, we infected pre-diabetic mice with MCMV. One-week p.i. we observed that DIO, but not infection increased FPG concentrations ( Figure 3H ). In addition, one-week p.i. we analyzed gluconeogenesis by pyruvate tolerance test (PTT). In line with FPG concentrations, we observed that HFD increased gluconeogenesis following pyruvate challenge. However, infection did not result in enhanced, but even in somewhat reduced gluconeogenesis ( Figure 3I ). In addition, hepatocytes from HFD-fed mice showed reduced induction of AKT phosphorylation (pAKT) in response to insulin challenge compared to NCDfed mice, whereas infection did not further impair this process ( Figure 3J ). Finally, hepatocyte-specific ablation of the IFNgR1 using Alb cre Ifngr1 flox/flox animals (Ifngr1 DHep ) did not result in a reduction of IR or GI following infection of pre-diabetic mice ( Figure S3C ). To confirm that infection does not result in hepatic insulin resistance, we calculated the endogenous glucose production rate (EGP) under basal conditions and after infusion of insulin during a hyperinsulinemic-euglycemic clamp study. We did not observe an impact of infection on EGP under either condition ( Figure 3K ). Thus, infection-induced IR and GI is mediated independently of macrophages, adipocytes, and hepatocytes. Next, we considered skeletal muscle as a target tissue. Skeletal muscle is responsible for 70%-75% of insulin-induced glucose absorption (DeFronzo et al., 1981; Shulman et al., 1990) . We noticed that infection, but not DIO increases IFN-g transcription in skeletal muscle 7 days post infection ( Figure S4 ). Therefore, we hypothesized that infection directly targets insulin sensitivity of muscle cells. Indeed, we observed that infection reduced pAKT in muscle of lean and obese animals upon insulin challenge ( Figure 4A ). This effect was IFN-g-dependent, since we did not observe this effect in Ifng À/À mice ( Figure 4B ). Moreover, Ckmm cre Ifngr1 flox/flox mice (Ifngr1 DMyo ), which lack the IFNgR1 receptor on myocytes, were protected from infectioninduced IR and GI ( Figure 4C ). To demonstrate that infection specifically impairs glucose uptake into skeletal muscle in response to insulin, mice were subjected to hyperinsulinemiceuglycemic clamping and were injected with a bolus of radioactive 2-deoxy glucose at the end of the steady state period. We noted that glucose uptake in muscle was strongly reduced following infection, whereas internalization in VAT was not affected ( Figure 4D ).
These results demonstrate that skeletal muscle cells are the main targets of IFN-g induced IR and progression of DM2 following infection.
Interferon-g Drives Insulin Resistance of Skeletal
Muscle Cells through Downregulation of the Insulin Receptor Next, we sought to elucidate how infection-induced IFN-g drives IR in muscle. Infection did not affect total Akt protein expression, suggesting that IFN-g impairs upstream insulin receptor signaling. No differences were observed in transcription of Irs1 and Irs2 ( Figure S5A ). Also, we found no increase in Socs1 or Socs3, which are known targets of IFN-g and known inhibitors of insulin signaling (Wormald et al., 2006) (Figure S5B ). In contrast, transcription of Insr, coding for the insulin receptor, was significantly reduced in muscle, but not in liver of infected pre-diabetic mice ( Figure 5A ). Moreover, we found that infection of WT, but not Ifng À/À mice with MCMV resulted in downregulation of insulin receptor expression on transcriptional and protein amounts in muscle (Figure 5B-5D ; S5C and S5D). Likewise, infection with LCMV or Influenza A also resulted in downregulation of Insr in muscle ( Figure S5E ). To investigate whether IFN-g alone induces downregulation of Insr or whether this effect is only achieved in the context of viral infection, we injected IFN-g daily in the m. sartorius of NCD or HFD primed mice. We observed that IFN-g injection alone was able to cause upregulation of MHC II, a bona fide downstream target of IFNgR signaling, on muscle tissue macrophages ( Figure S5F ) and downregulation of Insr transcript in muscle but not in the liver (Figure 5E, S5G) .
Because MCMV infection has a long-lasting negative effect on insulin sensitivity, at least in pre-diabetic mice, we wanted to (K) B6 mice were mock-infected or infected with MCMV and endogenous glucose production was analyzed 5 days later during hyper-insulinemic-euglycemic clamp. (H) Pooled data of 12 experiments (n = 60) is shown (analyzed by ANOVA with Bonferroni post-testing). The experiment in Figure 3K was performed once. Other graphs show one of two or more experiments with similar results. For (A-G) and (I-K) five mice were used in each group. Indicated are means ± SEM. and statistical significances at *p < 0.05, **p < 0.01, ***p < 0,001 by student's t test or ANOVA followed by Bonferroni post-testing. p.i., post infection. See also Figure S3 . elucidate whether 3 weeks p.i. Insr is still downregulated in muscle. We observed that transcription of Insr in muscle of HFD primed MCMV infected mice are still downregulated at this time point ( Figure 5F ).
Taken together, these results show that infection-induced IFN-g drives IR in skeletal muscles through downregulation of the insulin receptor, resulting in GI in pre-diabetic animals.
Infection-Induced Insulin Resistance Promotes Antiviral CD8 + T Cell Responses Finally, we questioned the physiological relevance of IFN-ginduced IR. In lean animals, infection did not induce hyperglycemia, excluding increased nutrient availability as a cause. However, viral infection did cause hyperinsulinemia. Because insulin receptor and CD28 signaling both converge on PI3K (Frauwirth et al., 2002) , we hypothesized that insulin might directly provide co-stimulation for CD8 + T cells. We observed that CD8 + T cells expressed both Insr and Irs2, but not Irs1 ( Figure 6A ). Indeed, stimulation of primed CD8 + T cells with insulin rapidly induced phosphorylation of S6 kinase ( Figure 6B ), a downstream target of insulin-signaling. Next, we stimulated OT-1 CD8 + T cells in vitro with SIINFEKL peptides and/or aCD28 antibodies in the presence or absence of insulin. Proliferation and viability were not affected by insulin ( Figures S6A and S6B ). In contrast, cytokine and Granzyme B production were enhanced by insulin, especially upon CD28 co-stimulation ( Figure 6C ). To confirm these findings in vivo in an obesity-independent model of hyperinsulinemia, lean mice were injected daily with basal (long-acting) insulin. Unlike short-working insulin used in ITT, basal insulin is slowly released in the blood stream and causes a continuous state of hyperinsulinemia. Basal insulintreated animals were infected with MCMV and CD8 + T cell responses were analyzed after 7 days. We observed that hyperinsulinemia promoted effector cell formation and cytokine production of virus-specific CD8 + T cells ( Figures 7A and 7B ).
To test the importance of insulin on CD8 + T cell priming in a second model, we generated Ins2 cre iDTR mice, which allow elimination of insulin-producing pancreatic beta cells by injection of diphtheria toxin (DT). DT-treatment of Ins2 cre iDTR abrogated their ability to produce insulin in response to a glucose bolus ( Figures S7A-S7C ), but did not result in overt morbidity at least one week after treatment. DT-treated Ins2 cre iDTR or iDTR littermates were infected with MCMV and CD8 + T cell responses were analyzed one week later. DT-treatment caused reduction in the number of virus-specific CD8 + T cells upon MCMV infection and impaired their cytokine production (Figures 7C and and Ifng À/À mice were NCD or HFD-fed for 6 weeks, followed by MCMV infection. After 7 days mice were fasted overnight, followed by injection with insulin. After 30 minutes, skeletal muscle samples were isolated and pan-Akt and pAkt amounts were determined by immunoblotting. (C) Pre-diabetic Ifngr1 DMyo mice and Ifngr1 flox/flox littermates were injected with MCMV or PBS. 5 and 7 days p.i., mice were subjected to ITT and GTT.
(D) Glucose uptake into VAT and skeletal muscle during hyperinsulinemic-euglycemic clamping 5 days after MCMV infection of NCD fed mice. The experiment in (D) was performed once. In (A) and (B) density quantification plot shows pooled data from two independent experiments. For (C) a representative of three experiments is shown. For (A)-(D), five mice per experiment were used in each group. Indicated are means ± SEM and statistical significances at *p < 0.05, **p < 0.01, ***p < 0,001 by (D) Student's t test or (A-C) ANOVA followed by Bonferroni post-testing. p.i., post infection. See also Figure S4 . Figure 7F ). Moreover, CD8 + T cells showed impaired cytokine production upon in vitro re-stimulation ( Figure 7G ). Thus, we have identified insulin as a molecule which promotes antiviral-effector CD8 + T cell responses.
7D). Finally, after MCMV infection, DT-treated
DISCUSSION
Our research has addressed the question how viral infection contributes to development of DM2. We found that the activated immune system drove systemic IR in response to infection with various viruses, but not GI due to compensatory insulin output by the pancreas. In case of pre-existing metabolic dysfunction caused by DIO, compensatory mechanisms were overloaded and long-term loss of glycemic control ensued. We discovered that virally-induced IFN-g directly and specifically targeted skeletal muscle to downregulate the insulin receptor and promoted compensatory hyperinsulinemia to boost the CD8 + T cell-mediated antiviral immune response. Thus, here we have identified a physiological feed-back mechanism between the immune and endocrine systems, which operates in viral infection and we demonstrate that this mechanism represents an ''Achilles heel'' for deregulation of glycemic control in pre-diabetic obese subjects. Current opinion in the field holds that IR is a derailed physiological response to systemic inflammation that aims to increase the systemic glucose set point to ensure optimal nutrient availability for activated immune cells (Kotas and Medzhitov, 2015) . Indeed, extreme conditions, such as severe trauma or sepsis are able to induce hyperglycemia (Dungan et al., 2009) . Chronic injection of high-doses of LPS, a mouse model for severe sepsis (Doi et al., 2009) , is shown to induce hepatic insulin resistance and increase FPG through modification of the mevalonate pathway (Okin and Medzhitov, 2016) . However, this so-called stress hyperglycemia is only observed in critically ill patients (Dungan et al., 2009) and not following common infections such as we have investigated. Activated CD8 + T cells dramatically increase their requirement for glucose to satisfy needs for growth, proliferation, and effector function . Nevertheless, glucose uptake rather than glucose availability has been shown to be the rate limiting step for effector CD8 + T cell function . Indeed, even at glucose concentrations that were 10-fold lower than those normally observed during homeostasis, maximal CD8 + T cell effector function was achieved in the presence of sufficient co-stimulation . This seems at odds with the observation that starvation promotes lethality upon influenza infection of mice, which could be prevented by oral glucose gavage (Wang et al., 2016) . However, caloric supplementation during viral infection does not induce loss of glycemic control (Wang et al., 2016) . Our findings suggest that glucose administration during infection promotes immune responses indirectly by increasing systemic insulin concentrations. Indeed, when we abrogated insulin production in mice, we observed reduced CD8 + T cell responsiveness, despite a state of systemic hyperglycemia. CD28 provides one of the strongest co-stimulatory signals for activation of CD8 + T cells through the activation of several signaling cascades, including the PI3K pathway (Rudd et al., 2009) . The insulin receptor exclusively signals through PI3K, thus sharing a major signaling cascade with CD28. Indeed, we found that insulin stimulation of CD8 + T cells during priming enhanced the costimulatory effects of CD28 and functioned as a pro-inflammatory cytokine. Immune cell-mediated increase of insulin availability at the time of CD8 + T cells priming, therefore benefits the immune response. However, immune-mediated adjustment of insulin production comes at a risk of inducing loss of glucose homeostasis and should therefore be carefully regulated. For example, if IFN-g would directly stimulate pancreatic insulin production, it would induce potentially lethal hypoglycemia. Similarly, induction of IR in liver or VAT would result in an increase of FPG or circulating free fatty acids, respectively (Karpe et al., 2011; Leto and Saltiel, 2012; Meshkani and Adeli, 2009) . By targeting insulin sensitivity of muscle, increased insulin production by the pancreas both boosts the antiviral immune response, while ensuring blood glucose homeostasis. Muscle IR could cause reduced motility, but this is in fact a desirable behavior upon infection (Wang et al., 2016) . Recently, it has been shown that under homeostatic conditions macrophagederived IL-1b can promote insulin secretion which stimulates glucose uptake in immune cells . Our findings indicate that IL-1b does not reduce systemic glucose uptake following infection. However, neutralization of IL-1b resulted in enhanced glucose intolerance following infection, suggesting that immune-endocrine interactions operate at multiple levels to increase systemic insulin concentrations. The role of obesity-induced visceral adipose tissue inflammation in development of IR has been well described. Adipocyte hypertrophy promotes accumulation of pro-inflammatory cells with a Th1 cell-signature, such as CD8 + T cells and M1 macrophages. Cytokines such as TNF, IL-6, and IL-1b produced by these cells leak into circulation and induce insulin resistance (Johnson et al., 2012) . We and others have shown that NK-cell-derived IFN-g promotes development of IR indirectly by driving conversion of adipose tissue macrophages (ATMs) toward an M1 phenotype (O'Rourke et al., 2012; Wensveen et al., 2015a) . Infectioninduced IR appears to operate independently of VAT. Moreover, we have demonstrated in vivo that IFN-g is able to induce IR directly in non-immune cells. In vitro, IFN-g had been shown to cause IR in 3T3-L1 adipocytes and myoblasts by inhibiting insulin receptor signaling through induction of suppressor of cytokine signaling (SOCS) molecules (Grzelkowska-Kowalczyk and Wieteska-Skrzeczy nska, 2009; McGillicuddy et al., 2009; Wada et al., 2011) . We show that in vivo IFN-g specifically reduced glucose uptake in skeletal muscle by downregulation of the insulin receptor. Expression was normalized to Hprt.
(B) Purified OT-1 cells were stimulated with SIINFEKL (N4) peptide in the presence or absence of anti-CD28. After 2 days, cells were rested from stimuli for 3 hr, followed by stimulation with 1 U/ml of insulin. Kinetics of S6 phosphorylation were determined by flow cytometry. Representative plot shows cells primed with N4 and aCD28 at 0 and 15 min after insulin stimulation.
(C) Purified OT-1 cells were stimulated with N4 peptide alone or in the presence of insulin and/ or anti-CD28. After 48 hr, cells were re-stimulated with N4 peptide and production of Granzyme B, IFN-g, and TNF was measured by flow cytometry. For (A-C) a representative of at least three experiments is shown. For (A)-(C) at least three samples were used in each group Indicated are means ± SEM and statistical significances at *p < 0.05, **p < 0.01, ***p < 0,001 by (C) ANOVA followed by Bonferroni post-testing. See also Figure S6 .
DM2 affects almost half a billion of people worldwide with tens of millions more at risk of developing this disease (American Diabetes Association, 2018). In this study we showed that viral infection was a hyperglycemia-inducing ''event'' that was able to drive rapid transition from pre-diabetes to diabetes. Infectious diseases such as cytomegalovirus and influenza, for which we show that they cause IR in humans and mice, affect most of the human population (Colugnati et al., 2007) . Prospective studies show that IR develops years to decades before onset of DM2.
Increased b cell output of insulin compensates IR, resulting only in a marginal increase of FPG and 2HG (Tabá k et al., 2009) . When insulin resistance reaches a level that cannot be compensated anymore by increased insulin production of the pancreas, blood glucose values rapidly rise and DM2 ensues. We found that infection-induced IR was able to push animals beyond this threshold. However, the metabolic state of the subject (i.e., is hepatic IR established), as well as the nature and intensity of the infection appear to be crucial for determining whether the effect quantified in spleen. In addition, (G) splenocytes were re-stimulated in vitro with two different viral peptides and production of IFN-g and TNF was analyzed by flow cytometry. For (A-E) five mice and for (F and G) eight mice were used in each group. Representative of two or more experiments is shown. Indicated are means ± SEM and statistical significances at *p < 0.05, **p < 0.01, ***p < 0,001 by (A-G) Student's t test. p.i., post infection. See also Figure S7 .
of the infection will be transient or permanent. Our results therefore have direct implications for the way health care specialists should approach infections or vaccination strategies in patients with pre-diabetes, since prevention of DM2 might be most effective at the time of this transition (Mason et al., 2007) . Our findings indicate that, in addition to well established criteria such as obesity, hypertension and high triglyceride concentrations in circulation, viral infection should be considered as an important risk factor for development of DM2, especially in patients with prediabetes (American Diabetes Association, 2018).
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: backcrossed at least ten times with C57BL/6J mice. Male mice (8-12 weeks old) were fed ad libitum either with NCD (SSNIFF) or with HFD in which 50% of calories was derived from animal fat (Bregi). All animal experiments were approved by the National Committee for welfare of animals.
VIRUSES
The bacterial artificial chromosome-derived murine cytomegalovirus (BAC-MCMV) strain pSM3fr-MCK-2fl clone 3.3 has previously been shown to be biologically equivalent to the MCMV Smith strain (VR-1399; ATCC) and is referred to as wild-type (WT) MCMV (Wagner et al., 2013) . pSM3fr-MCK-2fl clone 3.3 and Dm157 (Hirche et al., 2017) were propagated on mouse embryonic fibroblasts (MEF). Animals were infected intravenously i.v. with 2x10 5 PFU. Viral titers were determined on MEF by standard plaque assay.
Lymphocytic choriomeningitis virus (LCMV) Armstrong strain (Armstrong E-350; ATCC) was propagated on baby mouse kidney cells according to standard protocol. Animals were infected intraperitoneally i.p. with 10 6 PFU. Influenza A strain A/PR/8/34 (ATCC) was generated in LLC-MK2 cells and TCID 50 was determined in wild-type B6 mice. Mice were infected intranasally with 10 x TCID 50 under ketamine/xylazine anesthesia.
GLUCOSE TOLERANCE, INSULIN TOLERANCE, AND PYRUVATE TOLERANCE TEST
For glucose tolerance (GTT) and insulin tolerance (ITT) tests mice were fasted for 6 h and then injected with 1g/kg of D-glucose (Sigma) i.p. or with 1 U/kg of human fast working insulin (Aspart, Novo Nordisk) dissolved in saline solution, respectively. In the end of ITT mice were injected i.p. with 1 g/kg of D-glucose (Sigma) to prevent consequence of the hypoglycemia. To measure pyruvate tolerance (PTT), mice were fasted for 16 h and then injected with 1 g/kg i.p. of pyruvate sodium solution (Sigma). Glucose was measured in blood from the v. saphena with an automated glucometer (SD. Codefree). ITT is a standard metabolic test that is commonly used to assess sensitivity of the insulin receptor before and after insulin administration, while GTT measures glucose disposal after glucose challenge. These two tests are commonly used to detect impairments in glucose metabolism.
INSULINOGENIC INDEX
To investigate the impact of the infection on insulin secretion we calculated insulinogenic index. Insulinogenic index is defined as a ratio between insulin areas and glucose areas under curve during GTT .
GLUCOSE CLAMP STUDIES
Hyperinsulinemic-euglycemic clamp studies were performed in freely moving mice as described (Wueest et al., 2010) . Mice were anesthetized with isofluran and eye ointment was applied to both eyes. A catheter (MRE 025, Braintree Scientific, Braintree, MA, USA) was inserted into the left jugular vein and exteriorized at the neck. Two to three days after surgery, DMEM (control) or 2x10 5 PFU MCMV virus dissolved in DMEM was injected via catheter. Five days p.i., hyperinsulinemic-euglycemic clamp was performed.
Insulin was infused at a constant rate (12 mU/kg*min) and steady state glucose infusion rate was calculated once glucose infusion reached a more or less constant rate for 15-20 min with blood glucose concentrations at 5-6 mmol/l. The glucose disposal rate was calculated by dividing the rate of [3-3H] glucose infusion by the plasma [3-3H] glucose specific activity. Endogenous glucose production during the clamp was calculated by subtracting the glucose infusion rate from the glucose disposal rate. In order to assess tissue specific glucose uptake, a bolus (10 mCi) of 2-[ 
ELISA
To analyze serum insulin concentrations, animals were fasted overnight and injected with 1 g/kg of D-glucose. Blood was isolated from the v. saphena using heparin coated plastics. Insulin was measured in plasma using the mouse ultrasensitive insulin ELISA kit (Alpco). IFN-g concentrations were measured with the mouse IFN-gamma Platinum ELISA (eBioscience) according to manufacturer's protocol. Plates were analyzed using a Mithras LB940 ELISA plate reader (Berthold technologies).
IMMUNOBLOT
After overnight fasting, mice were injected with 1 U/kg of human fast working insulin (Aspart, Novo Nordisk). After 30 min VAT, liver and muscle were isolated and snap-frozen in liquid nitrogen. Samples were lysed in Triton lysis buffer (50 mM HEPES, 1% Triton X-100, 10 mM EDTA, 0.1% SDS, 50 mM NaCl, complete ULTRA Tablets, Mini, Easypack (Protease inhibitor cocktail tablets) (Roche) and PhosStop EASYpack (Phosphatase inhibitor cocktail tablets) (Roche) in a tissue homogenizer. Protein contents were determined by the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) and equal amounts of total lysate were analyzed by 12% SDS-polyacrylamide gel electrophoresis. Proteins were transferred to Immobilon-P and incubated with blocking buffer (Tris buffered saline/Tween-20) containing 2% low-fat milk for 1 h before incubating with an antibody against the insulin receptor, p-Akt (Ser
473
) and pan-Akt from Cell Signaling. Bands were visualized with ECL Prime Immuno Blotting Detection Reagent (GE Healthcare) using ImageQuant LAS 4000mini (GE Healthcare, Life Science). Density of bands was calculated relative to pan-Akt using ImageJ software.
QUANTITATIVE PCR
Muscle (m. sartorius) or liver pieces were lysed in Trizol with a tissue homogenizer. RNA was isolated via the Trizol method (Invitrogen), and cDNA was generated with a reverse transcriptase core kit (Eurogentec). The expression of mRNA was examined by quantitative PCR with a 7500 Fast Real Time PCR machine (ABI). Taqman assays were used to quantify the expression of Ifng 
ANTIBODIES AND FLOW CYTOMETRY
Antibodies for in vivo applications (CD4 (YTS191.1.2), CD8 (YTS169.4.2), NK1.1 (PK136), IFN-g (R4-6A2), Il-1b (BE0246) and isotype controls were produced by our in-house facility or purchased from BioXcell. For flow cytometry, single-cell suspensions of spleen were prepared according to standard protocols. Flow cytometric analysis were performed by using anti-mouse mouse CD4 (GK1.5), CD3 (145-2C11), CD8b (53-6.7), CD62L (MEL-14), CD127 (A7R34), KLRG1 (2F1), NK1.1 (PK136), CD11b (M1/70), CD11c (N418), CD86 (GL1), GR1 (RB6 8C5), F4/80 (BM8), TNF (MP6-XT22), IFN-g (XMG1.2) and granzyme B (NGZB) from eBioscience, preceded by blocking of Fc receptors using 2.4G2 antibodies (in house generated). To measure cytokine production, cells were stimulated with 1 mg of MCMV peptides M57 (SCLEFWQRV) or m139 (TVYGFCLL) or with SIINFEKL (N4) peptide for 4 h in the presence of Brefeldin A (10 mg/ml; eBioscience). MHC class I tetramers were provided by A. ten Brinke (Amsterdam, the Netherlands). For intracellular staining, permeabilization and fixation of cells was done with the Fix/Perm kit (BD Biosciences). All data were acquired using a FACSVerse (BD Biosciences) and analyzed using FlowJo software (Tree Star).
HUMAN DATA
Patients in the age group of 18-70yrs, diagnosed with acute respiratory infection (Influenza, Human respiratory syncytial virus (HRSV)) were recruited from the Department of Infectology at the Clinical Medical Center of Rijeka. Pneumonia was diagnosed with chest X-ray. Influenza and HRSV were determined by PCR on RNA isolated from nasopharyngeal swabs by our clinical diagnostics laboratory. Patients suffering from kidney failure, chronic inflammatory or autoimmune diseases or patients with a previous history of glucose intolerance or diabetes (anamnesis and HbA1c) were excluded from this study. Whole blood was drawn on two-time points: acute infection (days 1-7 from the onset of symptoms) and post illness period (90-100 days after first analysis). Insulin concentrations were measured in plasma by electro-chemiluminescence immunoassay (ECLIA) on a Cobas E411 analyzator (Roche, Switzerland) and HbA1c were measured in full blood using a turbidimetric inhibition immunoassay (TINIA) on a Cobas 501 analyzator (Roche, Switzerland). Body mass index of every patient was determined at first analysis. Fasting insulin and glucose concentrations were used to calculate HOMA-IR as described (Matthews et al., 1985) . An informed consent was obtained from patients after the nature and possible consequences of the studies were explained. This study was approved by the University of Rijeka Medical Faculty Ethics Committee before initiation.
METHODS PERFORMED IN VIVO
VATectomy was done as described (Wensveen et al., 2015a) . In brief, mice either underwent sham operation or had periepididymal fat pad removed (VATectomy). Two weeks after surgery, mice were placed on NCD or HFD and infected with MCMV or left untreated. For adoptive transfer, NK cells were isolated and purified using biotinylated DX5 antibodies, streptavidin-coated beads and magnetic cell sorting (Miltenyi) from spleen and blood. Purity was determined by flow cytometry. 5x10 6 NK cells were transferred i.v. in to Ifng À/À mice one day before infection and three days after initial transfer. For induction of liver damage using CCL 4 , mice were treated twice a week with 200 mL of a 10% solution of CCL 4 diluted in mineral oil. To induce liver damage with paracetamol, animals received 100 mg/kg of paracetamol dissolved in PBS twice per week. For depletion of macrophages, mice were injected once weekly with 45 mg/kg of clodronate liposomes or with unloaded liposomes as a control starting one day before infection. Poly I:C was injected i.p. twice per week at 200 mg per mouse. MCC950 (Cayman Chemical) was administrated i.p. every second day at doses of 20 mg/kg.
